Pharma Journalist 8791 posts 0 comments

WHO released a Global Influenza Strategy for 2019-2030 aimed at protecting people in all countries from the threat of influenza. The goal of the strategy is to prevent seasonal…
Read More...

Biogen announced that it has entered into a share purchase agreement with FUJIFILM Corporation (Fujifilm) under which Fujifilm will acquire the shares of Biogen’s subsidiary, which…
Read More...

Pfizer Inc. announced the United States (U.S.) Food and Drug Administration (FDA) has approved TRAZIMERA (trastuzumab-qyyp), a biosimilar to Herceptin (trastuzumab), for the treatment…
Read More...

Secura Bio announced that it has acquired the global rights to Farydak (panobinostat) from Novartis. Farydak (panobinostat) is a prescription oral medication used in combination with…
Read More...

Xencor, a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of autoimmune disease, asthma and allergic diseases, and cancer, today…
Read More...

SMi’s 2nd annual Injectable Drug Delivery Conference is returning to London on the 15th and 16th May 2019. SMi Group are delighted to have Dr Joël Richard chairing the two-day…
Read More...

SMi Group Reports: The 7th Annual Conference for Lyophilisation taking place on the 3rd- 4th of June plus a two day interactive workshop on the 5th of June 2019 in London, UK.…
Read More...

Gilead Sciences, Inc. announced findings from two studies that support the further development of GS-6207, a novel, selective, first-in-class inhibitor of HIV-1 capsid function, for…
Read More...

Douglas Cusato from Sumitomo Rubber Industries will be speaking next month at The 6th annual Pre-Filled Syringes East Coast Conference in Boston, where he will discuss the current…
Read More...

Bayer has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for darolutamide for the treatment of patients with non-metastatic…
Read More...